ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined w...
Maryam Abdolmaleki, Leslie S. Gaynor, Dan-Dan Liu et al.· Annals of Clinical and Trans...· 2 citations
Subclinical reductions in cardiac output relate to cognitive decline. We examined the relationship between cardiac output and cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease pathologies in 153 participants from the Vanderbilt Memory and Aging Project. Linear regression and linear mixed effects regression mo...
Amalia J. Peterson, Yun-Yi Sun, Dan-Dan Liu et al.· Journal of Alzheimer's Disea...· 0 citations
ASL-sCoV may serve as an important hemodynamic measure for identifying perfusion deficits tied to SVD burden and progression and could provide substantial insight into the longitudinal clinical consequences of SVD.
W. Robb, Ava M. Santner, Pan-Pan Zhang et al.· Stroke· 0 citations
DORES provides a multimodal nnU-Net-based pipeline for ePVS segmentation in older adults and demonstrates robust within-cohort performance and reasonable external validity, though scanner-related effects limit application across sites.
James D. LeFevre, W. Robb, Dan-Dan Liu et al.· Magnetic Resonance Imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.